Role of p21 and oxidative stress on renal tubular resistance after acute ischaemic injury

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 1795-1803

  Kfouri, Flavia ^a   De Castro, Isac ^a   Testagrossa, Leonardo ^a   Delle, Humberto ^a   Da Silva, Ana Maria Gonçalves ^a   Bastos, Ana Paula Almeida ^a   Vieira Jr , Jose Mauro ^a   Yu, Luis ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Oxidative stress; P21; Renal ischaemia; Tubular resistance

Indexed keywords

HYDROPEROXIDE; LACTATE DEHYDROGENASE; PROTEIN P21; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ACUTE KIDNEY TUBULE NECROSIS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; HYPOXIA; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE; LYMPHOCYTE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REOXYGENATION; UREA BLOOD LEVEL;

ACUTE DISEASE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CREATININE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA PRIMERS; ISCHEMIA; KIDNEY TUBULES; L-LACTATE DEHYDROGENASE; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 77952979220     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp719     Document Type: Article

References (40)

1. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996; 334: 1448-1460
2. Behrends M, Walz MK, Kribben A et al. No protection of the porcine kidney by ischaemic preconditioning. Exp Physiol 2000; 85: 819-827
3. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/re- perfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001; 276: 11870-11876
4. Joo JD, Kim M, D'Agati VD et al. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfu-sion injury in mice. J Am Soc Nephrol 2006; 17: 3115-3123
5. Zager RA, Burkhart KM, Gmur DJ. Postischemic proximal tubular resistance to oxidant stress and Ca2+ ionophore-induced attack. Implications for reperfusion injury. Lab Invest 1995; 72: 592-600
6. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-491
7. Daemen MA, Heemskerk VH, Van't VC et al. Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-anti-trypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 2000; 102: 1420-1426
8. Kaizu T, Tamaki T, Tanaka M et al. Preconditioning with tin-proto-porphyrin IX attenuates ischemia/reperfusion injury in the rat kidney. Kidney Int 2003; 63: 1393-1403
9. Burne-Taney MJ, Liu M, Baldwin WM et al. Decreased capacity of immune cells to cause tissue injury mediates kidney ischemic preconditioning. J Immunol 2006; 176: 7015-7020
10. Megyesi J, Udvarhelyi N, Safirstein RL et al. The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure. Am J Physiol 1996; 271: F1211-F1216
11. Megyesi J, Andrade L, Vieira JM Jr et al. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 2001; 60: 2164-2172
12. Megyesi J, Safirstein RL, Price PM. Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 1998; 101: 777-782
13. Price PM, Safirstein RL, Megyesi J. Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 2004; 286: F378-F384
14. Megyesi J, Andrade L, Vieira JM Jr et al. Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol 2002; 283: F810-F816
15. Miyaji T, Kato A, Yasuda H et al. Role of the increase in p21 in cis-platin-induced acute renal failure in rats. J Am Soc Nephrol 2001; 12: 900-908
16. Ohkawa H, Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; v.95: 351-358
17. Dijkstra CD, Dopp EA, Joling P et al. The heterogeneity of mononu-clear phagocytes in lymphoid organs: distinct macrophage subpopu-lations in rat recognized by monoclonal antibodies ED1, ED2 and ED3. Adv Exp Med Biol 1985; 186: 409-419
18. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 1990; 96: 121-129
19. Alibaud L, Llobera R, Al ST et al. A new monoclonal anti-CD3ep-silon antibody reactive on paraffin sections. J Histochem Cytochem 2000; 48: 1609-1616
20. Barcaui CB, Goncalves da Silva AM, Sotto MN et al. Stem cell ap-optosis in HIV-1 alopecia. J Cutan Pathol 2006; 33: 667-671
21. Vieira JMJr, Rodrigues LT, Mantovani E et al. Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease. Nephron Physiol 2005; 101: 82-91
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
23. Yu L, Gengaro PE, Niederberger M et al. Nitric oxide: a mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 1994; 91: 1691-1695
24. Bergmeyer H. Methods in Enzimatic analysis. 2nd ed USA: New York, 1974:, 1974;
25. Jiang ZY, Woollard AC, Wolff SP. Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids 1991; 26: 853-856
26. Zager RA, Baltes LA, Sharma HM et al. Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney Int 1984; 26: 689-700
27. Cochrane J, Williams BT, Banerjee A et al. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat. Ren Fail 1999; 21: 135-145
28. Behrends M, Walz MK, Kribben A et al. No protection of the porcine kidney by ischaemic preconditioning. Exp Physiol 2000; 85: 819-827
29. Guo Y, Wu WJ, Qiu Y et al. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol 1998; 275: H1375-H1387
30. Joo JD, Kim M, D'Agati VD et al. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice. J Am Soc Nephrol 2006; 17: 3115-3123
31. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/re- perfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001; 276: 11870-11876
32. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-491
33. Ysebaert DK, De Greef KE, Vercauteren SR et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000; 15: 1562-1574
34. Persy VP, Verhulst A, Ysebaert DK et al. Reduced postischemic mac-rophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 2003; 63: 543-553
35. Kluth DC, Erwig LP, Rees AJ. Multiple facets of macrophages in renal injury. Kidney Int 2004; 66: 542-557
36. Park SK, Kang MJ, Kim W et al. Renal tubule regeneration after ischemic injury is coupled to the up-regulation and activation of cyclins and cyclin dependent kinases. Kidney Int 1997; 52: 706-714
37. Lee YJ, Lee JH, Han HJ. Extracellular adenosine triphosphate protects oxidative stress-induced increase of p21(WAF1/Cip1) and p27(Kip1) expression in primary cultured renal proximal tubule cells: role of PI3K and Akt signaling. J Cell Physiol 2006; 209: 802-810
38. Tarry-Adkins JL, Ozanne SE, Norden A et al. Lower antioxidant capacity and elevated p53 and p21 may be a link between gender disparity in renal telomere shortening, albuminuria, and longevity. Am J Physiol Renal Physiol 2006; 290: F509-F516
39. Shim J, Lee H, Park J et al. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 1996; 385: 804
40. Zager RA, Burkhart KM, Gmur DJ. Postischemic proximal tubular resistance to oxidant stress and Ca2+ ionophore-induced attack. Implications for reperfusion injury. Lab Invest 1995; 72: 592-600